Ligand validation:7VAZ

NGA: 2-acetamido-2-deoxy-beta-D-galactopyranose

NGA is a Ligand Of Interest in 7VAZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VAZ_NGA_G_101	59%	45%	0.148	0.943	0.46	1.64	-	1	1	0	93%	0.9333
7V7K_NGA_C_102	71%	3%	0.126	0.946	2.85	3.09	6	5	0	0	100%	0.9333
7V64_NGA_C_101	57%	31%	0.114	0.899	0.46	2.22	-	4	4	0	93%	0.9333
7V8Q_NGA_H_101	30%	57%	0.267	0.934	0.62	1.02	-	-	0	0	100%	0.9333
7VAC_NGA_I_202	18%	59%	0.322	0.914	0.63	0.94	-	-	4	0	100%	0.9333
5T52_NGA_A_303	97%	32%	0.065	0.982	0.9	1.78	1	5	0	0	100%	1
1WMZ_NGA_C_503	95%	15%	0.059	0.96	1.07	2.63	1	11	0	0	100%	1
2Z48_NGA_A_1003	93%	56%	0.067	0.963	0.55	1.15	-	2	0	0	100%	1
6S22_NGA_F_201	93%	45%	0.069	0.964	1.12	1	1	-	0	1	100%	0.9333
3GH7_NGA_A_1300	93%	28%	0.088	0.982	0.85	2.01	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.